Researchers have discovered a combination of compounds that may help in the treatment of Peyronie’s disease in its active phase, according to a recent study in European Urology. After testing 21 substances in an phenotypic screening assay and working with rat models, they determined that the combination of vardenafil [a phosphodiesterase type 5 (PDE5) inhibitor] […]
When diagnosing Peyronie’s disease, there are a number of factors to consider, including the degree of curvature, the size and characteristics of plaques, the presence of pain, and the ability to have an erection suitable for intercourse…
Unfortunately, some medical procedures can result in penile shortening. In a recent paper published by Sexual Medicine Reviews, researchers looked at various studies on penile size and the effects of surgical treatments for Peyronie’s disease, erectile dysfunction (ED), and prostate cancer.
Men with Peyronie’s disease could be at higher risk for certain types of cancer. A study involving over 1.7 million men found higher risk of stomach cancer, melanoma, and testicular cancer among men with Peyronie’s disease when compared to men with erectile dysfunction (ED).
New research in the Journal of Sexual Medicine reports that injections of collagenase Clostridium histolyticum (CCH) can be a safe and effective way to treat Peyronie’s disease in its acute phase.
In recent years, many studies have investigated the use of stem cells in treatments for male sexual problems, such as erectile dysfunction (ED) and Peyronie’s disease. While many of these projects show some promise, further study is needed before such therapies can be deemed beneficial, according to a recent article in Sexual Medicine Reviews.